Pharmaceutical Regulatory Affairs and IPR

Diadelis Remirez Figueredo has received her BA in Biochemistry from Havana University, Cuba and both her MSc in Biomedicine and PhD in Pharmaceutical

Sciences from National Center for Scientific Research in Havana and most of the results were done in the Department of Toxicology at the Free University in

Amsterdam. Her Postdoctoral training in Molecular Toxicology and Pharmacology was completed at the Faculty of Pharmacy in Toronto, Canada. She has been a referee of scientific journals. She has been the recipient of National Award of Pharmacology twice from the Cuban Pharmacology Society. She has worked as an expert for the evaluation of preclinical platform in South Africa (CSIR). She is currently the Vice President of Cuban Pharmacology Society. Presently she works in the Cuba Regulatory Agency and she is one of the Reviewers for authorization of clinical trials. She is the Project Leader about Pharmacogenetic guideline. She belongs to Iberoamerican Pharmacogenetic Network (RIBEF) since 2008 and recently obtained Master degree in Clinical Trials. Her research is described in over 30 published research reports.